| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 03/11/2004 | WO2003009845A9 Substituted urea neuropeptide y y5 receptor antagonists |
| 03/11/2004 | WO2003000185A3 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
| 03/11/2004 | WO2002083709A3 Kinases and phosphatases |
| 03/11/2004 | WO2002079441A3 Secreted proteins |
| 03/11/2004 | WO2002076404A3 Fatty alcohol drug conjugates |
| 03/11/2004 | US20040049083 Arylpiperazines having activity at the serotonin 1A receptor |
| 03/11/2004 | US20040049072 RXR modulators with improved pharmacologic profile |
| 03/11/2004 | US20040049046 Small molecule inhibitors of rotamase enzyme activity |
| 03/11/2004 | US20040049038 N-substituted with a methylene-bridged nonaromatic ring system, e.g., N-(2-(benzyloxy)-5,6,7,8,9,10-hexahydro-6,9-methanobenzo(a)(8)annulen-11-yl)-N'-(2,2,2-trifluoroethyl)-sulfamide; preventing or treating Alzheimer's Disease |
| 03/11/2004 | US20040049032 Inhibitors of protein kinases, especially Aurora kinase; anticancer agents |
| 03/11/2004 | US20040049017 A protein complex which includes a growth factor, growth factor binding protein and vitronectin; for treating cancers, psoriasis, atherosclerosis and wounds prone to hypertrophic scarring |
| 03/11/2004 | US20040049014 Production of non-immunogenic antibodies having strong affinity for a predetermined antigen |
| 03/11/2004 | US20040048933 Autonomic nerve regulating agent |
| 03/11/2004 | US20040048931 Modafinil pharmaceutical compositions |
| 03/11/2004 | US20040048929 E.g., N-(4-fluorophenylsulfonyl)-L-valyl-L-leucinal stabilized with a lipid; improved absorption and penetration; treating ischemia, immune diseases, Alzheimer's disease, osteoporosis, brain disorders, eye diseases, osteoporosis |
| 03/11/2004 | US20040048927 Pharmaceutical preparation comprising eicosapentaenoic acid and/or stearidonic acid |
| 03/11/2004 | US20040048924 Ibuprofen composition |
| 03/11/2004 | US20040048920 2-(p-(1-hydrocarbylsulfonylalkyl)phenyl)-1,1,1,3,3,3-hexafluoro-2-propanol derivatives; treating atherosclerosis, dyslipidemia, diabetes, Alzheimers disease, and Niemann-Pick disease. |
| 03/11/2004 | US20040048919 Related to premenstrual syndrome, premenstrual dysphoric disorder, perimenopause, menopause, or side effects of hormonal contraceptives; combination of polyunsaturated fatty acid and tocopherol derivative, most of which is not alpha |
| 03/11/2004 | US20040048912 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 03/11/2004 | US20040048907 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof |
| 03/11/2004 | US20040048903 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes |
| 03/11/2004 | US20040048901 Increased water solubility and bioabsorption; treatment of CNS disorders such as depression and emesis |
| 03/11/2004 | US20040048897 Il-8 receptor antagonists |
| 03/11/2004 | US20040048893 Hydrolysis and decarboxylation of 1-alkyl- or aralkyl-4-((2-hydrocarbyloxycarbonyl-5,6-dimethoxyindan-1-one)-2 -yl)methylpiperidine |
| 03/11/2004 | US20040048889 Use of non-competitive and selective glur5 antagonists as gultamate receptor modulating compounds |
| 03/11/2004 | US20040048884 3-aminoalkyluracil derivatives, e.g., 1-(2,6-Difluorobenzyl)-5-(3-methoxyphenyl)-6-methyl-3-(N-methyl-N-(2 -pyridylethyl)-aminoethyl)uracil; contraceptives; treating lupus, sex hormone related cancer, benign prostatic hypertrophy, etc. |
| 03/11/2004 | US20040048882 4-phenyl-6-alpha-(imidazolyl-, 1,2,4-triazolyl- or pyridyl)-benzyl substituted |
| 03/11/2004 | US20040048881 Quinazoline derivatives with anti-tumour activity |
| 03/11/2004 | US20040048872 Sedatives, anticonvulsants, hypnotics and general anesthetics. |
| 03/11/2004 | US20040048869 Dopamine D4 receptor antagonist with antidepressant or anxiolytic agent. |
| 03/11/2004 | US20040048867 Especially quinoline carbonyl pyrrolidines with binding selectivity to benzodiazepine site of GABAA receptor to treatanxiety, depression, a sleep disorder, or cognitive impairment. |
| 03/11/2004 | US20040048862 Chemical compounds |
| 03/11/2004 | US20040048860 Use of selective noradrenaline reuptake inhibitors for the treatment of tension-type headache |
| 03/11/2004 | US20040048859 Substituted glutarimides and their use as inhibitors of IL-12 production |
| 03/11/2004 | US20040048857 Treatment and/or prevention of diseases or disorders mediated by lymphocyte interactions. |
| 03/11/2004 | US20040048856 Monoamine reuptake inhibitors for treatment of CNS disorders |
| 03/11/2004 | US20040048855 Inhibitors of interleukin 1-beta converting enzyme |
| 03/11/2004 | US20040048854 From 4-amino-2-methyl-10H-thieno(2,3-b)(1,5) benzodiazpine HCl and 1-methylpiperazine in an aprotic high boiling solvent; purifying in an acid medium; basifying to pH of 7.5-9; and extracting with a low boiling organic solvent |
| 03/11/2004 | US20040048852 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 03/11/2004 | US20040048849 Cyclin-dependent kinase (cdk) and glycolene synthase kinase-3 (gsk-3) inhibitors |
| 03/11/2004 | US20040048848 Novel gamma secretase inhibitors |
| 03/11/2004 | US20040048843 And aza- and diaza-derivatives thereof; especially treating allergy or nasal congestion |
| 03/11/2004 | US20040048840 Modulation of matrix metalloproteinase (MMP) activity with aldosterone blocker(s) |
| 03/11/2004 | US20040048830 Administering a cyclic oligosaccharide such as 6-per-deoxy-6-per-(2,3- dihydroxypropylthio)- gamma -cyclodextrin; treating depression and other psychological disorders such as Cushing's syndrome, schizophrenia and severe anxiety |
| 03/11/2004 | US20040048828 Immunosuppressive agent and food |
| 03/11/2004 | US20040048827 Regulation of the expression of genes as beta -secretase, presenilin-1, presenilin-2 gamma -amyloid protein precursor. |
| 03/11/2004 | US20040048820 Prevention or therapy of cardiovascular complications |
| 03/11/2004 | US20040048801 Use of activity-dependent neurotrophic factor-derived polypeptides for enhancing learning and memory:pre-and post-natal administration |
| 03/11/2004 | US20040048795 Stimulating a vagus nerve pathway in the brain; inhibiting apoptosis of a cardiac myocyte |
| 03/11/2004 | US20040048373 Production and long-term in vitro culture of these cell populations, and the use of neuroblasts in the treatment of various neuronal disorders as well as the identification of compositions which affect neuroblasts |
| 03/11/2004 | US20040048372 Extracting and recovering embryonic-like stem cells, including pluripotent or multipotent stem cells, from an exsanguinated human placenta; use of the isolated and perfused placenta as a bioreactor in which to propagate endogenous/exogenous cells |
| 03/11/2004 | US20040048338 IL-17 receptor like molecules and uses thereof |
| 03/11/2004 | US20040048294 Diagnostic and therapeutic methods useful for diagnosing and treating diseases, disorders, and/or conditions related to these novel human secreted proteins |
| 03/11/2004 | US20040048266 Regulation of human membrane-type serine protease |
| 03/11/2004 | US20040048263 Novel g protein-coupled receptor protein and dna thereof |
| 03/11/2004 | US20040048256 Isolated polypeptide of given sequence; use in screening for identifying therapeutic antibodies and drugs |
| 03/11/2004 | US20040048245 Isolated polypeptide of given sequence; identifying modulators by contacting with compound and detecting binding activity; use in diagnosis and treatment |
| 03/11/2004 | US20040047907 Controlled release hydrocodone formulations |
| 03/11/2004 | US20040047851 Treating a subject suffering from a condition associated with an extracellular zinc sphingomyelinase activity which comprises administering to the subject an amount of a zinc sphingomyelinase inhibitors effective to decrease |
| 03/11/2004 | US20040047807 Neurotoxic substances, which have a toxic effect in particular for the axon and the nociceptive nerve endings, for the preparation of an agent for the treatment of joint pain. |
| 03/11/2004 | DE10240343A1 Peroxynitrit-Umlagerungskatalysatoren Peroxynitrite rearrangement catalysts |
| 03/11/2004 | DE10240035A1 Biogene Polyester-Partikel definierter Größe mit funktionalisierten Oberflächen:Herstellungsverfahren und pharmazeutische Zubereitungen, in denen diese enthalten sind Biogenic polyester particles of defined size with functionalized surfaces: Method and pharmaceutical preparations in which they are contained |
| 03/11/2004 | DE10238723A1 Phenyl-substituierte Pyrazolyprimidine Phenyl-substituted Pyrazolyprimidine |
| 03/11/2004 | DE10238722A1 Improving attention, concentration, cognition, learning and/or memory performance, using selective phosphodiesterase 9A inhibitors, preferably 4H-pyrazolo-(3,4-d)-pyrimidin-4-one derivatives |
| 03/11/2004 | CA2497255A1 Method for producing biodegradable, functionalised polymer particles, and use of the same as medicament carriers |
| 03/11/2004 | CA2497161A1 Herbal extract comprising a mixture of saponins obtained from sapindus trifoliatus for anticonvulsant activity |
| 03/11/2004 | CA2496920A1 Adenosine a2a receptor antagonists for treating restless legs syndrome or related disorders |
| 03/11/2004 | CA2496798A1 Embossable and writable multilaminate backing construction |
| 03/11/2004 | CA2496695A1 New therapeutic uses of (4-(2-fluorophenyl)-6-methyl-2(1-piperazinyl)thieno{2,3-d}pyrimidine |
| 03/11/2004 | CA2495914A1 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
| 03/11/2004 | CA2495853A1 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12 |
| 03/11/2004 | CA2495248A1 Anabaseine derivatives useful in the treatment of neurodegenerative diseases |
| 03/11/2004 | CA2493199A1 Peroxynitrite rearrangement catalysts used for the treatment or prophylaxis of diseases caused by peroxynitrite-mediated reactions |
| 03/10/2004 | EP1396493A1 Heterocyclic compounds |
| 03/10/2004 | EP1396492A1 Prodrug of an ice inhibitor |
| 03/10/2004 | EP1396488A1 Fused heterocyclic compound and medicinal use thereof |
| 03/10/2004 | EP1396271A1 Use of germination-activated ganoderma lucidium spores as anti-aging agent and against menopause symptoms |
| 03/10/2004 | EP1395684A2 New polynucleotides and polypeptides of the ifnalpha-7 gene |
| 03/10/2004 | EP1395652A2 Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same |
| 03/10/2004 | EP1395605A2 Polymeric immunoglobulin fusion proteins that target low-affinity fcgamma receptors |
| 03/10/2004 | EP1395602A2 Novel human potassium channel beta subunit |
| 03/10/2004 | EP1395591A1 Corticotropin releasing factor antagonists |
| 03/10/2004 | EP1395586A2 Method for the production of zolpidem |
| 03/10/2004 | EP1395583A1 New phenylpiperazines |
| 03/10/2004 | EP1395582A1 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same |
| 03/10/2004 | EP1395578A1 Carbazole derivatives and their use for the preparation of pharmaceutical compositions for the treatment of npy related diseases |
| 03/10/2004 | EP1395576A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 03/10/2004 | EP1395575A1 4-(penyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 03/10/2004 | EP1395574A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 03/10/2004 | EP1395568A1 4-aminopyrimidine derivatives |
| 03/10/2004 | EP1395567A1 4 (phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders |
| 03/10/2004 | EP1395566A1 Tricyclic compounds useful as angiotensin ii agonists |
| 03/10/2004 | EP1395561A1 Carbamate and oxamide compounds as inhibitors of cytokine production |
| 03/10/2004 | EP1395560A1 2-oxo-piperidinyl- and 2-oxo-azepanyl alkanoic acid derivativ es for the treatment of epilepsy and other neurological disorders |
| 03/10/2004 | EP1395559A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders |
| 03/10/2004 | EP1395558A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 03/10/2004 | EP1395557A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 03/10/2004 | EP1395556A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 03/10/2004 | EP1395555A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derativatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |